drugset / Trial / NCT00411866

Effects Of The Drug Ketoconazole On How The Body Handles The Drug SB773812

NCT00411866

Phase 1 Completed 36 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelDiagnostic

Summary

The purposes of this study are to determine if there is a difference in how SB-773812 is distributed through the bloodstream before and after multiple doses of ketoconazole have been given and to determine if there is a difference in how safe and well tolerated SB-773812 is when given on its own and given with ketoconazole.

Timeline

Start
2006-10-13
Primary completion
2007-10-10
Completion
2007-10-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoconazole Small molecule 400 mg Oral
Subject SB773812 Small molecule 20 mg Oral

Indications